176 related articles for article (PubMed ID: 24762141)
1. Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.
Nölting S; Giubellino A; Tayem Y; Young K; Lauseker M; Bullova P; Schovanek J; Anver M; Fliedner S; Korbonits M; Göke B; Vlotides G; Grossman A; Pacak K
Endocrinology; 2014 Jul; 155(7):2377-90. PubMed ID: 24762141
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
Fliedner SM; Engel T; Lendvai NK; Shankavaram U; Nölting S; Wesley R; Elkahloun AG; Ungefroren H; Oldoerp A; Lampert G; Lehnert H; Timmers H; Pacak K
PLoS One; 2014; 9(5):e97712. PubMed ID: 24846270
[TBL] [Abstract][Full Text] [Related]
3. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
Zhang X; Zhong S
Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
[TBL] [Abstract][Full Text] [Related]
4. Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.
Martiniova L; Perera SM; Brouwers FM; Alesci S; Abu-Asab M; Marvelle AF; Kiesewetter DO; Thomasson D; Morris JC; Kvetnansky R; Tischler AS; Reynolds JC; Fojo AT; Pacak K
Endocr Relat Cancer; 2011 Feb; 18(1):143-57. PubMed ID: 21098082
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma Cells.
Schovanek J; Bullova P; Tayem Y; Giubellino A; Wesley R; Lendvai N; Nölting S; Kopacek J; Frysak Z; Pommier Y; Kummar S; Pacak K
Endocrinology; 2015 Nov; 156(11):4094-104. PubMed ID: 26267380
[TBL] [Abstract][Full Text] [Related]
6. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.
Lai EW; Joshi BH; Martiniova L; Dogra R; Fujisawa T; Leland P; de Krijger RR; Lubensky IA; Elkahloun AG; Morris JC; Puri RK; Pacak K
J Clin Endocrinol Metab; 2009 Aug; 94(8):2952-7. PubMed ID: 19491224
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
Bullova P; Cougnoux A; Marzouca G; Kopacek J; Pacak K
Endocrinology; 2017 Oct; 158(10):3097-3108. PubMed ID: 28938421
[TBL] [Abstract][Full Text] [Related]
9. Propofol Prevents the Progression of Malignant Pheochromocytoma In Vitro and In Vivo.
Wang H; Zhang S; Zhang A; Yan C
DNA Cell Biol; 2018 Apr; 37(4):308-315. PubMed ID: 29565198
[TBL] [Abstract][Full Text] [Related]
10. Strain-specific metastatic phenotypes in pheochromocytoma allograft mice.
Ullrich M; Liers J; Peitzsch M; Feldmann A; Bergmann R; Sommer U; Richter S; Bornstein SR; Bachmann M; Eisenhofer G; Ziegler CG; Pietzsch J
Endocr Relat Cancer; 2018 Oct; 25(12):993-1004. PubMed ID: 30288966
[TBL] [Abstract][Full Text] [Related]
11. Cytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell lines.
Powers JF; Korgaonkar PG; Fliedner S; Giubellino A; Pacak K; Sahagian GG; Tischler AS
PLoS One; 2014; 9(2):e87807. PubMed ID: 24516563
[TBL] [Abstract][Full Text] [Related]
12. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence of duality effects for lovastatin in a nude mouse cancer model.
Wang CY; Shui HA; Chang TC
Int J Cancer; 2010 Jan; 126(2):578-82. PubMed ID: 19621388
[TBL] [Abstract][Full Text] [Related]
14. Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
Pang Y; Yang C; Schovanek J; Wang H; Bullova P; Caisova V; Gupta G; Wolf KI; Semenza GL; Zhuang Z; Pacak K
Oncotarget; 2017 Apr; 8(14):22313-22324. PubMed ID: 28423608
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma.
Kato Y; Salumbides BC; Wang XF; Qian DZ; Williams S; Wei Y; Sanni TB; Atadja P; Pili R
Mol Cancer Ther; 2007 Jan; 6(1):70-81. PubMed ID: 17237267
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial Inhibition of mTORC2 and Hsp90 Leads to a Distinctly Effective Therapeutic Strategy in Malignant Pheochromocytoma.
Zhang X; Gao F; Zhong S
Curr Cancer Drug Targets; 2019; 19(9):698-706. PubMed ID: 30727894
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
Niemeijer ND; Alblas G; van Hulsteijn LT; Dekkers OM; Corssmit EP
Clin Endocrinol (Oxf); 2014 Nov; 81(5):642-51. PubMed ID: 25041164
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.
Zhang L; Scorsone K; Woodfield SE; Zage PE
Cancer Chemother Pharmacol; 2015 Nov; 76(5):977-87. PubMed ID: 26407819
[TBL] [Abstract][Full Text] [Related]
19. Paraganglioma: not just an extra-adrenal pheochromocytoma.
Laird AM; Gauger PG; Doherty GM; Miller BS
Langenbecks Arch Surg; 2012 Feb; 397(2):247-53. PubMed ID: 22086065
[TBL] [Abstract][Full Text] [Related]
20. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
